GSK and Pfizer Join Forces to Create New HIV Firm

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 4 (Table of Contents)

Published: 16 Apr-2009

DOI: 10.3833/pdr.v2009.i4.1096     ISSN: 1756-7874

Section: Joint Venture



GlaxoSmithKline and Pfizer have agreed to pool their resources in HIV to create a new specialist company that will hold 19% of the market for HIV treatments. The two companies said that it will be more sustainable and broader in scope than either company's individually. GSK will have an 85% stake in the joint venture and Pfizer will have 15%.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details